Health-related quality of life in Dutch men with prostate cancer

Journal of Psychosocial Oncology

Volumn 24, Issue 2, 2006, Pages 49-64

  Voerman, Bert ^a   Fischer, Maarten ^a   Visser, Adriaan ^a   Garssen, Bert ^a   Van Andel, George ^b   Bensing, Jozien ^c  

^a HELEN DOWLING INSTITUTE   (Netherlands)

^b ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^c NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

Author keywords

Health related quality of life; Hormonal therapy; Prostate cancer; Prostatectomy

Indexed keywords

HORMONE;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; COGNITIVE DEFECT; DISEASE SEVERITY; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE C30; EUROPEAN ORGANIZATION FOR RESEARCH AND TREATMENT OF CANCER QUALITY OF LIFE QUESTIONNAIRE PR25; FATIGUE; FUNCTIONAL ASSESSMENT; HUMAN; JOY OF LIFE QUESTIONNAIRE; MAJOR CLINICAL STUDY; MALE; NETHERLANDS; OUTCOME ASSESSMENT; PAIN; PROSTATE CANCER; PROSTATECTOMY; QUALITY OF LIFE; QUALITY OF LIFE INDEX; QUESTIONNAIRE; ROLE PLAYING; SEXUAL FUNCTION; SYMPTOM;

ADULT; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; ANTINEOPLASTIC AGENTS, HORMONAL; COMBINED MODALITY THERAPY; CROSS-SECTIONAL STUDIES; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; PROSTATECTOMY; PROSTATIC NEOPLASMS; QUALITY OF LIFE; QUESTIONNAIRES; RADIOTHERAPY, ADJUVANT; REPRODUCIBILITY OF RESULTS; SEXUAL BEHAVIOR;

EID: 33749581219     PISSN: 07347332     EISSN: 15407586     Source Type: Journal    
DOI: 10.1300/J077v24n02_04     Document Type: Article

References (30)

1. Aaronson, N.K. 15011/30011: An international field study of the reliability and validity of the EORTC QLQ-C30 and a disease specific questionnaire module (The QLQ-PR25 for assessing the quality of life of patients with prostate cancer. 2002. European Organisation for Research and Treatment of Cancer.
2. Aaronson, N.K., Ahmedzai, S., Bergman, B., Bullinger, M., Cull, A.M., & Duez, M.J. (1993). The European Organisation for Research and Treatment of Cancer QLQ C30: a quality-of-life instrument for use in international clinical trials in oncology. Journal of the National Cancer Institute., 85, 365-376.
3. Andel, G.v. & Kurth, K.H. (2003). The impact of androgen deprivation therapy on health related quality of life in asymptomatic men with lymph node positive prostate cancer. Euopean Urology, 44, 209-214.
4. Aus, G., Abbou, C.C., Pacik, D., Schmid, H.P., Van Poppel, H., Wolff, J.M., & Zattoni, F. (2001). European Association of Urology guidelines on prostate cancer. European Urology, 40, 97-101.
5. Beard, C.J., Propert, K.J., Rieker, P.P., Clark, J.A., Kaplan, I., Kantoff, P.W., & Talcott, J.A. (1997). Complications after treatment with external-beam irradiation in early-stage prostate cancer patients: A prospective multi-institutional outcome study. Journal of Clinical Oncology, 15, 223-229.
6. Black, R.J., Bray, F., Ferlay, J., & Parkin, D.M. (1997). Cancer incidence and mortality in the European Union: Cancer registry data and estimates of national incidence for 1990. European Journal of Cancer, 33, 1075-1107.
7. Bruin, E.J. de. & Dijk, M. van. HDI - Health and Disease Inventories, een meet instrument voor aanpassing aan kanker. Handleiding. 1996. Lisse, Swets en Zeitlinger.
8. Caffo, O., Fellin, G., Graffer, U., & Luciani, L. (1996). Assessment of quality of life after radical radiotherapy for prostate cancer. British Journal of Urology, 78, 557-563.
9. Catalona, W.J. (1994). Management of cancer of the prostate. New England Journal of Medicine, 331, 996-1004.
10. Cella, D.F. & Tulsky, D.S. (1993). Quality of life in cancer: Definition, purpose, and method of measurement. Cancer Invest, 11, 327-336.
11. Davinson, P.J., Ouden D. van den, & Schroeder, F.H. (1996). Radical prostatectomy: Prospective assessment of mortality and morbidity. European Urolology, 29, 168-173.
12. Fayers, P.M., Aaronson, N.K., Bjordal, K., & Groenvold, M. EORTC QLQ-C30 Scoring Manual (Second edition). 1999. Brussels, EORTC.
13. Feld, R. (1995). Endpoints in cancer clinical trials: Is there a need for measuring quality of life? Supportive Care in Cancer, 3, 23-27.
14. Gulden, J.W.v.d., Kiemeney, L.A., Verbeek, A.L., & Straatman, H. (1994). Mortality trend from prostate cancer in the Netherlands (1950-1989). Prostate, 24, 33-38.
15. Hamilton, A.S., Stanford, J.L., Gilliland, F.D., Albertsen, P.C., Stephenson, R.A., Hoffman, R.M., Eley, J.W., Harlan, L.C., & Potosky, A.L. (2001). Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: Results from the Prostate cancer outcome study. Journal of Clinical Oncology, 7, 178-185.
16. Hautmann, R.E., Sauter, T.W., & Wenderoth, U.K. (1994). Radical retropubic prostatectomy: Morbidity and urinary continence in 418 concecutive cases. Urology, 43, 47-51.
17. Hedestig, O., Sandman, P., & Witmark, A. (2003). Living with untreated localized prostate cancer. Cancer Nursing, 26, 55-60.
18. Landis, S.H., Murray, T., Bolden, S., & Wingo, P.A. (1998). Cancer statistics, 1998. CA. Cancer J. Clin., 48, 6-29.
19. Lee, W.R., Hall, M.C., McQuellon, R.P., Case, L.D., & McCullough, D.L. (2001). A prospective quality-of-life study in men with clinically localized prostate carcinoma treated with radical prostatectomy, external beam radiotherapy, or interstitial brachytherapy. International Journal of Radiation Oncology, Biology, Physics, 51, 614-623.
20. Lilleby, W., Fossa, S.D., Waehre, H.R., & Olsen, D.R. (1999). Long-term morbidity and quality of life in patients with localized prostate cancer undergoing definitive radiotherapy or radical prostatectomy. Int. J. Radiat. Oncol. Biol. Phys., 43, 735-743.
21. Litwin, M.S., Fitzpatrick, J.M., Fossa, S.D., & Newling, D.W. (1999a). Defining an international research agenda for quality of life in men with prostate cancer. Prostate, 41, 58-67.
22. Litwin, M.S., Mc Guigan, K.A., Shpall, A.I., & Dhanani, N. (1999b). Recovery of health-related quality of life in the year after radical prostatectomy: Early experience. Journal of Urology, 161, 515-519.
23. Macdonagh, R. (1996). Quality of life and its assessments in urology. British Journal of Urology, 78, 485-496.
24. Moinpour, C.M. (1994). Measuring quality of life: An emerging science. Seminars in Oncology, 21, 48-60.
25. Potosky, A.L., Legler, J., Albertsen, P.C., Stanford, J.L., Gilliland, F.D., Hamilton, A.S., Eley, J.W., Stephenson, R.A., & Harlan, L.C. (2000). Health outcomes after prostatectomy or radiotherapy for prostate cancer: Results from the Prostate Cancer Outcomes Study. J. Natl. Cancer Inst., 92, 1582-1592.
26. Shipley, W.U., Zietman, A.L., Hanks, G.E., Coen, J.J., Caplan, R.J., Won, M., Zagars, G.K., & Asbell, S.O. (1994). Treatment related sequelae following external beam radiation for prostate cancer: A review with an update in patients with stages T1 and T2 tumor. Journal of Urology, 152, 1799-1805.
27. Talcott, J.A., Rieker, P.P., Clark, J.A., Propert, K.J., Weeks, J.C., & Beard, C.J. (1998). Patient-reported symptoms after primary therapy for early prostate cancer: Results of a prospective cohort study. Journal of Clinical Oncology, 16, 275-283.
28. Visser, O., Coebergh, J.W.W., Schouten, L.J., Dijck, J.A.A.M.v., & Siesling, S. (2002). Incidence of Cancer in the Netherlands. Utrecht, Vereninging van integrale kankercentra.
29. Walsh, P.C., Partin, A.W., & Epstein, J.I. (1994). Cancer control and quality of life following anatomical radical retropubic prostatectomy: Results at 10 years. Journal of Urology, 152, 1831-1836.
30. Wasson, J.H., Cushman, C.C., Bruskewitz, R.C., Littenberg, B., Mulley, A.G.J., & Wennberg, J.E. (1993). A structured literature review of treatment for localized prostate cancer. Archives of Family Medicine, 2, 487-493.